Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

SRNE Stock Annual Cash Flow. Download in Excel

Sorrento Therapeutics Inc. logo

Sorrento Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.00
 
USD
  
0.00
  
(0.00%)
Previous close: 0.0005  Open: 0.0005  Bid:   Ask:
52 week range    
0.00   
   0.12
Mkt Cap: 0 M  Avg Vol (90 Days): 256,579
Peers   
KPTI / 
EXEL / 
ALDX / 
Last updated: Friday 10th January 2025

Stock Rankings

30
Technical
21
Quality
How are these ranks calculated?
Financials

SRNE Cash Flow

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in inventories-10 M
(Increase) Decrease in other current assets8 M23 M233000.0-1 M
(Increase) Decrease in other current liabilities-21 M-3 M-945000.0-362000.0-1 M-112 M
(Increase) Decrease in other working capital451000.0392000.0164000.01 M53 M23 M13 M9 M
(Increase) Decrease in payables878000.0-497000.0-3 M4 M2 M4 M10 M-4 M-4 M10 M
(Increase) Decrease in receivables117000.0-371000.0-176000.0-472000.0-515000.0-2 M-11 M-1 M-3 M-6 M
Acquisitions428000.0-4 M-557000.0-10 M-10 M-2 M
Amortization of intangibles4 M4 M4 M
AssetImpairmentCharge2 M124 M
CapitalExpenditureReported931000.0591000.04 M7 M11 M11 M11 M7 M9 M14 M
Cash at beginning of period5 M32 M72 M39 M82 M20 M213 M81 M56 M37 M
Cash at end of period32 M72 M39 M82 M20 M213 M81 M56 M37 M24 M
Cash flow-16 M-29 M-42 M-71 M-99 M-110 M-173 M-160 M-282 M-294 M
CashFlowFromContinuingInvestingActivities-503000.0-11 M-15 M-11 M-12 M-23 M-38 M-7 M116 M-14 M
ChangeInAccountPayable878000.0-497000.0-3 M4 M2 M4 M10 M-4 M-4 M10 M
ChangeInAccruedExpense-116000.02 M11 M2 M2 M6 M4 M-1 M21 M20 M
ChangeInInterestPayable-116000.02 M11 M2 M2 M6 M4 M-1 M21 M
ChangeInPayablesAndAccruedExpense762000.01 M8 M5 M4 M10 M14 M-5 M17 M30 M
ChangeInPrepaidAssets-441000.0-979000.0-1 M40000.0-2 M-3 M-314000.06 M-12 M7 M
ChangeInWorkingCapital438000.0229000.015 M28 M-18 M55 M25 M13 M10 M-91 M
CommonStockPayments-16 M
Current deferred income taxes-2 M33 M982000.0-36 M-6 M-373000.0-2 M-36 M-2 M
Deferred income taxes-2 M33 M982000.0-36 M-6 M-373000.0-2 M-36 M-2 M
Depreciation1 M3 M2 M3 M7 M9 M11 M11 M12 M13 M
Depreciation unreconciled1 M3 M2 M3 M8 M9 M15 M15 M16 M17 M
DepreciationAndAmortization1 M3 M2 M3 M8 M9 M15 M15 M16 M17 M
EarningsLossesFromEquityInvestments4 M-435000.040 M5 M4 M6 M126000.018 M
FinancingCashFlow44 M80 M-3 M132 M54 M326 M79 M174 M181 M312 M
Free cash flow-17 M-29 M-46 M-78 M-110 M-123 M-184 M-166 M-282 M-308 M
GainLossOnInvestmentSecurities-66 M-6 M828000.0-3 M37 M-7 M300000.077 M
GainLossOnSaleOfPPE59000.0440000.0
IncomeTaxPaidSupplementalData1000.06000.03 M2000.034000.06000.013000.01 M29000.0
InterestPaidSupplementalData2 M2 M1 M3 M2 M13 M3 M1 M1 M
Issuance of capital stock38 M72 M108 M58 M84 M
Issuance of debt21 M8 M19 M50 M96 M
IssuanceOfCapitalStock38 M72 M108 M58 M84 M
IssuanceOfDebt7 M8 M-3 M39 M-3 M173 M5 M-187 M-36 M-92 M
Net cash from financing activities44 M80 M-3 M132 M54 M151 M14 M-144 M-20 M-91 M
Net cash from investing activities-503000.0-11 M13 M-17 M-17 M-21 M-38 M-40 M80 M-29 M
Net cash from operating activities-16 M-29 M-42 M-71 M-99 M-112 M-173 M-160 M-282 M-294 M
Net change in cash & cash equivalents27 M40 M-33 M50 M-57 M193 M-132 M-25 M-21 M-11 M
Net income from continuing operations-22 M-35 M-50 M-64 M11 M-213 M-363 M-314 M-429 M-578 M
NetBusinessPurchaseAndSale428000.0-4 M-557000.0-10 M-10 M-2 M
NetCommonStockIssuance38 M72 M92 M58 M84 M
NetIntangiblesPurchaseAndSale-511000.0-10 M
NetInvestmentPropertiesPurchaseAndSale-10 M-11 M-2 M-17 M-31 M125 M
NetInvestmentPurchaseAndSale-10 M-11 M-2 M-17 M-31 M125 M
NetIssuancePaymentsOfDebt7 M8 M-3 M39 M-3 M173 M5 M-187 M-36 M-92 M
NetLongTermDebtIssuance7 M8 M-3 M39 M-3 M152 M-3 M-206 M-86 M-188 M
NetPPEPurchaseAndSale-420000.0-591000.0-4 M-7 M-11 M-11 M-11 M-7 M-9 M-14 M
Operating (gains) losses-62 M-33 M42 M8 M74 M56 M22 M55 M
Other financing charges net-1000000.0-2 M-1 M-22 M-55 M
Other investing changes net-2 M-17 M-31 M
Other non-cash items4 M4 M19 M-6 M-106 M36 M76 M73 M135 M305 M
PensionAndEmployeeBenefitExpense920000.06 M6 M5 M-111000.0-13 M
ProceedsFromStockOptionExercised17000.0304000.02 M524000.0211000.09 M98 M15 M1 M
Purchase of Float term investments-10 M-11 M
Purchase of property plant & equipment-931000.0-591000.0-4 M-7 M-11 M-11 M-11 M-7 M-9 M-14 M
Purchase of short term investments172 M
PurchaseOfIntangibles-511000.0-10 M
PurchaseOfInvestment-10 M-11 M
PurchaseOfPPE-420000.0-591000.0-4 M-7 M-11 M-11 M-11 M-7 M-9 M-14 M
Repayment of debt7 M8 M-3 M39 M-3 M-20 M-3 M-206 M-86 M-188 M
RepaymentOfDebt7 M8 M-3 M39 M-3 M-20 M-3 M-206 M-86 M-188 M
Repurchase of capital stock-16 M
Revenue per share477000.0550000.04 M4 M4 M4 M
Sale of short term investments125 M
SaleOfInvestment125 M
ShortTermDebtIssuance21 M8 M19 M50 M96 M
ShortTermDebtPayments-20 M
StockBasedCompensation2 M4 M7 M5 M5 M6 M13 M31 M90 M75 M
UnrealizedGainLossOnInvestmentSecurities665000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University